Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Kimura H, Suzuki M, Kanazawa M, Hori S, Aikawa N
Department of Emergency and Critical Care Medicine, School of Medicine, Keio University, Tokyo, Japan.
Intensive Care Med. 1996 Nov;22(11):1169-75. doi: 10.1007/BF01709331.
We studied blood MIP-1 alpha and IL-8 in 38 septic patients and 5 healthy volunteers. Both chemokines were undetectable in the healthy volunteers. In sepsis, serum MIP-1 alpha was detected in 45% of the patients and Il-8 in 84%. The levels of MIP-1 alpha, but not of IL-8, correlated with CRP, IL-6 and TNF alpha levels. Complications, including various organ failures and mortality, showed no correlation with serum MIP-1 alpha levels. In contrast, we found increased levels of serum IL-8 in septic patients with disseminated intravascular coagulation, central nervous system (CNS) dysfunction or renal failure, and the mortality rate was higher in the IL-8 detectable group than in the IL-8 undetectable group (50% vs 0%, p < 0.05). In conclusion, the production of both MIP-1 alpha and IL-8 was increased and initially detectable levels of circulating IL-8 predicted high mortality in sepsis.
To determine the significance of the C-C chemokine MIP-1 alpha and the C-X-C chemokine IL-8 in sepsis.
Prospective study.
Clinical investigation, emergency department and general intensive care unit of university hospital.
38 septic patients and 5 healthy volunteers were studied. Sepsis was diagnosed following the criteria formulated by ACCP/SCCM.
10-20 ml of blood was drawn from each patient at the time of initial diagnosis of sepsis.
MIP-1 alpha and IL-8 were determined by sandwich ELISA. Both chemokines were undetectable in the healthy volunteers. In sepsis, serum MIP-1 alpha was detected in 45% of the patients and IL-8 was detected in 84%. The levels of MIP-1 alpha, but not of IL-8, correlated with CRP, IL-6 and TNF alpha levels. Complications, including various organ failures and mortality, showed no correlation with serum MIP-1 alpha levels. In contrast, we found increased levels of serum IL-8 in patients with disseminated intravascular coagulation (DIC) (p < 0.05), central nervous system (CNS) dysfunction (p < 0.05), renal failure (p < 0.01) and the mortality rates were higher in the IL-8 detectable group than in the IL-8 undetectable group (50% vs 0%, p < 0.05).
The production of MIP-1 alpha and IL-8 was increased in sepsis. Furthermore, an initially detectable level of circulating IL-8, but not MIP-1 alpha, predicted a high mortality in sepsis diagnosed according to the ACCP/SCCM criteria.
我们研究了38例脓毒症患者和5名健康志愿者血液中的MIP-1α和IL-8。健康志愿者体内均未检测到这两种趋化因子。在脓毒症患者中,45%的患者血清中检测到MIP-1α,84%的患者检测到IL-8。MIP-1α水平与CRP、IL-6和TNFα水平相关,而IL-8水平则无此相关性。包括各种器官功能衰竭和死亡率在内的并发症与血清MIP-1α水平无关。相反,我们发现弥散性血管内凝血、中枢神经系统(CNS)功能障碍或肾衰竭的脓毒症患者血清IL-8水平升高,且IL-8可检测组的死亡率高于IL-8不可检测组(50%对0%,p<0.05)。总之,MIP-1α和IL-8的产生均增加,且循环IL-8的初始可检测水平预示着脓毒症患者的高死亡率。
确定C-C趋化因子MIP-1α和C-X-C趋化因子IL-8在脓毒症中的意义。
前瞻性研究。
大学医院急诊科和综合重症监护病房的临床研究。
研究了38例脓毒症患者和5名健康志愿者。根据ACCP/SCCM制定的标准诊断脓毒症。
在脓毒症初始诊断时,从每位患者抽取10 - 20毫升血液。
采用夹心ELISA法测定MIP-1α和IL-8。健康志愿者体内均未检测到这两种趋化因子。在脓毒症患者中,45%的患者血清中检测到MIP-1α,84%的患者检测到IL-8。MIP-1α水平与CRP、IL-6和TNFα水平相关,而IL-8水平则无此相关性。包括各种器官功能衰竭和死亡率在内的并发症与血清MIP-1α水平无关。相反,我们发现弥散性血管内凝血(DIC)患者(p<0.05)、中枢神经系统(CNS)功能障碍患者(p<0.05)、肾衰竭患者(p<0.01)血清IL-8水平升高,且IL-8可检测组的死亡率高于IL-8不可检测组(50%对0%,p<0.05)。
脓毒症中MIP-1α和IL-8的产生增加。此外,根据ACCP/SCCM标准诊断的脓毒症中,循环IL-8的初始可检测水平而非MIP-1α可预示高死亡率。